Search details
1.
Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical Trial.
J Infect Dis
; 226(9): 1537-1544, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-35134951
2.
Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever.
Cell Immunol
; 378: 104572, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35772315
3.
Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model.
Clin Infect Dis
; 64(8): 1066-1073, 2017 04 15.
Article
in English
| MEDLINE | ID: mdl-28158395
4.
Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model.
PLoS Pathog
; 11(5): e1004914, 2015 May.
Article
in English
| MEDLINE | ID: mdl-26001081
5.
Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans.
J Transl Med
; 14: 62, 2016 Mar 01.
Article
in English
| MEDLINE | ID: mdl-26928826
6.
An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution.
Clin Infect Dis
; 58(9): 1230-40, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24519873
7.
Addressing barriers to timely lung cancer diagnosis and treatment in an outer metropolitan Western Australian hospital.
Intern Med J
; 49(2): 279-280, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30754078
8.
Prospects for prevention of Salmonella infection in children through vaccination.
Curr Opin Infect Dis
; 26(3): 254-62, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23591641
9.
Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection.
Lancet Infect Dis
; 23(6): e218-e226, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36773621
10.
Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study.
JAC Antimicrob Resist
; 5(4): dlad091, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37533762
11.
Development and validation of a dynamic 48-hour in-hospital mortality risk stratification for COVID-19 in a UK teaching hospital: a retrospective cohort study.
BMJ Open
; 12(9): e060026, 2022 09 05.
Article
in English
| MEDLINE | ID: mdl-36691139
12.
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study.
Lancet Microbe
; 2(7): e291-e299, 2021 07.
Article
in English
| MEDLINE | ID: mdl-35544165
13.
Human Salmonella Typhi exposure generates differential multifunctional cross-reactive T-cell memory responses against Salmonella Paratyphi and invasive nontyphoidal Salmonella.
Clin Transl Immunology
; 9(9): e1178, 2020.
Article
in English
| MEDLINE | ID: mdl-33005416
14.
OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule.
BMJ Open
; 10(12): e042838, 2020 12 17.
Article
in English
| MEDLINE | ID: mdl-33334840
15.
Whole-Cell Pertussis Vaccination and Decreased Risk of IgE-Mediated Food Allergy: A Nested Case-Control Study.
J Allergy Clin Immunol Pract
; 8(6): 2004-2014, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31891824
16.
Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study.
Cell Rep Med
; 1(5): 100062, 2020 08 25.
Article
in English
| MEDLINE | ID: mdl-32838340
17.
Reply to Farmakiotis et al.
Clin Infect Dis
; 59(8): 1198-9, 2014 Oct 15.
Article
in English
| MEDLINE | ID: mdl-25077788
18.
Identification of the determinants of incomplete vaccination in Australian children.
Vaccine X
; 1: 100010, 2019 Apr 11.
Article
in English
| MEDLINE | ID: mdl-31384732
19.
The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis.
BMJ Open
; 9(11): e032549, 2019 11 14.
Article
in English
| MEDLINE | ID: mdl-31727664
20.
Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection study.
Vaccine
; 37(26): 3485-3494, 2019 06 06.
Article
in English
| MEDLINE | ID: mdl-31101422